Guardant Health’s blood test designed to help screen the population for hidden cases of colorectal cancer may have taken a step closer to FDA approval. An independent advisory panel convened by the ...

50 million Americans due for colon cancer screening avoid it because they consider traditional tests so unpleasant. But now it can be as simple as a blood test. If you’re overdue for your colon cancer ...

The Food and Drug Administration on Monday approved Guardant Health’s blood test, called Shield, to screen for colon cancer. The test isn't meant to replace colonoscopies, but is generating enthusiasm ...

Colorectal cancer is the third most diagnosed cancer in adults in the United States. Early detection could prevent more than 90% of colorectal cancer–related deaths, yet more than one third of the ...

Colon cancer is the second-deadliest cancer in the US, partly due to low screening rates. New and emerging screening tools, like blood and breath tests, may offer alternatives to in-office screenings.

At-home cancer test kits help detect and screen for cancers in their early, more treatable stage, sometimes before a person shows any symptoms. Share on Pinterest Cancer is the second leading cause of ...